Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scleroderma, Systemic | 4 | 2023 | 43 | 1.650 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2021 | 8 | 0.780 |
Why?
|
| Shock, Cardiogenic | 1 | 2021 | 2 | 0.740 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2018 | 158 | 0.610 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2017 | 7 | 0.590 |
Why?
|
| Adult | 6 | 2021 | 5913 | 0.260 |
Why?
|
| Humans | 9 | 2023 | 14537 | 0.250 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 171 | 0.250 |
Why?
|
| Prognosis | 2 | 2017 | 199 | 0.240 |
Why?
|
| Male | 6 | 2021 | 6754 | 0.240 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 253 | 0.230 |
Why?
|
| Raynaud Disease | 1 | 2023 | 5 | 0.220 |
Why?
|
| Rheumatic Diseases | 1 | 2023 | 17 | 0.210 |
Why?
|
| Rheumatology | 1 | 2023 | 18 | 0.210 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 217 | 0.210 |
Why?
|
| Female | 6 | 2021 | 9103 | 0.210 |
Why?
|
| Lasers | 1 | 2021 | 2 | 0.190 |
Why?
|
| Perfusion | 1 | 2021 | 6 | 0.190 |
Why?
|
| Middle Aged | 4 | 2018 | 3601 | 0.190 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2021 | 4 | 0.190 |
Why?
|
| Steroids | 1 | 2021 | 14 | 0.180 |
Why?
|
| Africa South of the Sahara | 1 | 2021 | 353 | 0.170 |
Why?
|
| Amino Acids | 1 | 2018 | 16 | 0.160 |
Why?
|
| Anti-Citrullinated Protein Antibodies | 1 | 2018 | 7 | 0.160 |
Why?
|
| HLA-DRB1 Chains | 1 | 2018 | 17 | 0.160 |
Why?
|
| Rheumatoid Factor | 1 | 2018 | 16 | 0.160 |
Why?
|
| Retrospective Studies | 2 | 2021 | 799 | 0.150 |
Why?
|
| African Americans | 1 | 2018 | 47 | 0.150 |
Why?
|
| Perfusion Imaging | 1 | 2018 | 1 | 0.150 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2018 | 2 | 0.150 |
Why?
|
| Protective Factors | 1 | 2017 | 7 | 0.150 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 20 | 0.150 |
Why?
|
| Databases, Factual | 1 | 2017 | 64 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 176 | 0.140 |
Why?
|
| South Africa | 5 | 2021 | 7596 | 0.140 |
Why?
|
| Odds Ratio | 1 | 2017 | 133 | 0.140 |
Why?
|
| Logistic Models | 1 | 2017 | 254 | 0.140 |
Why?
|
| Adolescent | 2 | 2021 | 2985 | 0.140 |
Why?
|
| Cause of Death | 1 | 2017 | 221 | 0.130 |
Why?
|
| Time Factors | 1 | 2017 | 507 | 0.130 |
Why?
|
| Child | 1 | 2021 | 2242 | 0.120 |
Why?
|
| Health Facility Closure | 1 | 2014 | 5 | 0.120 |
Why?
|
| Hospital Units | 1 | 2014 | 7 | 0.120 |
Why?
|
| Hospitals, Public | 1 | 2014 | 45 | 0.110 |
Why?
|
| Wrist Joint | 1 | 2013 | 3 | 0.110 |
Why?
|
| Ankle Joint | 1 | 2013 | 4 | 0.110 |
Why?
|
| Risk Factors | 1 | 2017 | 1475 | 0.110 |
Why?
|
| Aged | 2 | 2018 | 1740 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 468 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2013 | 321 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 563 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2013 | 967 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 1422 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2018 | 480 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 198 | 0.060 |
Why?
|
| Genotype | 2 | 2018 | 442 | 0.060 |
Why?
|
| Capillaries | 1 | 2023 | 1 | 0.050 |
Why?
|
| Nails | 1 | 2023 | 2 | 0.050 |
Why?
|
| Microscopic Angioscopy | 1 | 2023 | 2 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2021 | 43 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 80 | 0.050 |
Why?
|
| Alleles | 1 | 2018 | 143 | 0.040 |
Why?
|
| Haplotypes | 1 | 2018 | 125 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2018 | 179 | 0.040 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2014 | 4 | 0.030 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2014 | 4 | 0.030 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2014 | 4 | 0.030 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2014 | 4 | 0.030 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 1 | 2014 | 4 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2014 | 7 | 0.030 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2014 | 8 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 20 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 14 | 0.030 |
Why?
|
| Private Sector | 1 | 2014 | 45 | 0.030 |
Why?
|